BioPharma Dive covers the successes and setbacks of companies in the business of drug development. But with Unblinded, we wanted to go deeper. Published every four to six weeks, the series profiles decision makers who play central roles in the stories we cover, whether from positions at drugmakers, regulators or outside the industry.